1-3 of 3
Tanyel Kizeltepe, PHD
Close
Sort by
Journal Articles

CCR1 Inhibition Impairs Osteoclast Activity and Interaction with Myeloma Cells.

Sonia Vallet, MD, Noopur Raje, MD, Kenji Ishitsuka, MD, Teru Hideshima, MD, Klaus Podar, MD, Tanyel Kizeltepe, PHD, Hiroshi Yasui, MD, Shweta Chhetri, Enrique M. Ocio, MD, Janice Jin, Yutaka Okawa, MD, Hiroshi Ikeda, MD, Mario Boccadoro, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 3494.
https://doi.org/10.1182/blood.V108.11.3494.3494
Published: 2006
Journal Articles

MLN3897, a Novel CCR1 Antagonist, Inhibits Osteoclastogenesis by Blocking Early ERK Activation.

Sonia Vallet, MD, Noopur Raje, MD, Kenji Ishitsuka, MD, Teru Hideshima, MD, Klaus Podar, MD, Petter Veiby, Iris Breitkreutz, MD, Tanyel Kizeltepe, PHD, Hiroshi Yasui, MD, Enrique M. Ocio, MD, Norihiko Shiraishi, Marco Ladetto, MD, Mario Boccadoro, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2006) 108 (11): 1636.
https://doi.org/10.1182/blood.V108.11.1636.1636
Published: 2006
Journal Articles

The Role of B Cell-Activating Factor (BAFF) in the Biology of Multiple Myeloma (MM).

Noopur Raje, MD, Shaji Kumar, MD, Teru Hideshima, MD, PhD, Kenji Ishitsuka, MD, Hiroshi Yasui, MD, PhD, Yu-Tzu Tai, PhD, Norihiko Shiraishi, PhD, Tanyel Kizeltepe, PhD, Shweta Chhetri, BS, Sonia Vallet, MD, Robert L. Schlossman, MD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2005) 106 (11): 3380.
https://doi.org/10.1182/blood.V106.11.3380.3380
Published: 2005